Heart Cycle GEx (Guided- Exercise- Main Trial)

NACompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

November 30, 2013

Study Completion Date

November 30, 2013

Conditions
Coronary Artery Disease
Interventions
DEVICE

Guide Exercise (GEx-)- Training

Both intervention and control group undergo a baseline evaluation and an end evaluation including tests of the clinical routine like cardiopulmonary test (CPX), echocardiography and lactate measurement. They will also answer questionnaires referring to quality of life and the use of the system. During the training phase at home the interventional group will test the supervised training system during endurance training such as running, biking or walking and during resistance training such as performing exercise with rubber bands (at least 3x a week for about 5-6 months according to the generated prescription plan during training at the hospital). They will report their daily activity by diary. The control group will only report their physical activities by diary without using the Gex- System. At the end data are investigated to determine whether the supervised training with the GEx- System will improve the physical capacities ( VO2 peak) of patients.

DEVICE

Guided Exercise Training with an easy to wear vest with electrodes to measure ECG, respiration, activity

DEVICE

Control group training without Guided Exercise system at home

Trial Locations (1)

52074

Universtiy Hospital of Aachen, Department of Cardiology, Aachen

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Hospital Universitario La Paz

OTHER

collaborator

Hull University Teaching Hospitals NHS Trust

OTHER_GOV

collaborator

Cardiac and Pulmonary Rehabilitation Clinic An der Rosenquelle

UNKNOWN

collaborator

Universitat Politècnica de València

OTHER

collaborator

Medtronic

INDUSTRY

collaborator

Centre Suisse d'Electronique et de Microtechnique SA Switzerland

UNKNOWN

collaborator

German Sport University, Cologne

OTHER

lead

RWTH Aachen University

OTHER